FTSJ1

Across TCGA pan-cancer cohorts, FTSJ1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated FTSJ1 data layer compared with 28 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher FTSJ1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated FTSJ1 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

COAD, UCEC, and SKCM are the cancer types where FTSJ1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	II,III,IV	0.118	0.780	<.001	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
SKCM	OS	Median	II,III,IV	1.000	0.304	.040	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

FTSJ1–COAD (DFS)

Open the COAD breakdown →